Premier Biomedical Inc · OTC:BIEI

Premier Biomedical Inc financial statements

Premier Biomedical Inc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.02K14.3K39.8K39.8K0
Cost of revenue1.47K1.47K2.28K12.9K113.7K25.4K2.08K
Gross profit-1.47K-1.47K-1.26K1.42K-73.9K14.3K-2.08K
Research and development0184.3K113.9K
Selling, general and administrative328.2K618.9K1.12M524.0K
Operating income-87.4K-57.4K-171.0K-18.3K-6.47K-100.8K-327.0K-693.0K-1.29M-638.0K
Depreciation and amortization167.9K1.47K1.47K1.97K2.83K2.30K2.32K2.08K
EBITDA-3.10K-16.8K-5.00K-98.9K-324.2K-690.7K-1.29M-635.9K
Interest expense41.5K31.0K31.0K32.3K302.3K392.5K389.8K351.5K817.4K
Income before tax-87.4K-98.8K-202.0K-49.3K-38.8K-403.2K-374.0K-399.0K-3.76M-1.77M
Income tax-168.0K334392.5K389.8K4.31K817.4K
Net income-87.4K-98.8K-202.0K-49.3K-38.8K-403.2K-374.0K-399.0K-3.76M-1.77M
Earnings per share, basic-0.00-0.00-0.00-0.00-0.00-0.00-0.01-0.11-1.92-728.77

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents58934.21K71.2K86.8K83.7K22.4K
Short-term investments000
Receivables2.27K3.09K312
Inventory13.1K26.0K84.8K0
Current assets58934.21K93.7K159.8K203.6K33.9K
Property, plant and equipment7.22K5.20K5.48K5.10K
Goodwill000
Total assets3.19K3.23K7.35K3.13K3.13K4.60K100.9K165.0K209.1K39.0K
Accounts payable309.1K362.1K215.7K221.8K188.0K264.4K388.2K220.7K
Current liabilities2.61M2.58M2.49M2.28M2.25M2.22M1.93M2.31M2.82M699.7K
Long-term debt000
Total debt750.6K607.6K568.3K437.4K436.0K418.2K160.7K309.6K170.0K183.0K
Total liabilities2.61M2.58M2.49M2.28M2.25M2.22M1.93M2.31M2.82M699.7K
Shareholders' equity-2.61M-2.58M-2.48M-2.28M-2.25M-2.22M-1.83M-2.15M-2.61M-660.7K
Shares outstanding1.30B1.10B1.10B1.10B1000.0M796.5M52.4M3.50M1.96M2.43K

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-171.0K2.93K-5.00K-71.2K-344.2K-444.9K-507.1K-483.6K
Capital spending0000-4.85K-2.03K-2.70K-3.54K
Free cash flow-171.0K2.93K-5.00K-71.2K-349.0K-446.9K-509.8K-487.2K
Cash from investing-4.85K-2.03K-2.69K-3.54K
Cash from financing175.2K5.00K333.4K450.0K573.4K474.2K
Dividends paid000
Share buybacks090
Change in cash4.21K2.93K-8.99K-71.2K-15.6K3.12K63.6K-13.0K